Sarepta Therapeutics climbs 10%, rebounding from recent slide
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
More in Finance & Markets
Tether, Fasanara launch $400M private credit fund targeting $3B
The evergreen fund will use USDT infrastructure to support asset-backed lending through fintech platforms in more than 60 countries.
HarbourView Equity Partners hires Cambridge Associates alum as managing director
HarbourView Equity Partners is a multi-strategy investment firm focused on music, sports, media and entertainment, with approximately $3.88 billion in regulatory assets under management.
NuScale Power: 1 Catalyst That Will Make or Break This Nuclear Stock
NuScale Power's future hinges on one key catalyst.
The ‘Practical Magic 2’ Rotten Tomatoes Review Score Is In
Practical Magic 2 is here and it has amassed a Rotten Tomatoes critic review score. It has passed the first movie, but that comes with a caveat.
Consensys to split MetaMask into its own firm while staying silent on IPO
The existing company, Consensys Software Inc., will rebrand as MetaMask under Ethereum co-founder Joe Lubin as chairman and CEO.